Facts
- HQ
- Bothell, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 1998
- Type
- Corporation Seattle business license
- Employees
- 1,001–5,000
- Status
- Acquired
- Registered name
- SeaGen Inc Seattle business license
- Stage
- Public
Is this your organization? Claim it
Seattle’s Accipiter Bio Raises $12.7M, Partners with Pfizer and Kite Pharma to Advance AI-Designed Multi-Target Protein Therapies
Seattle biotech startup Accipiter Biosciences, founded by researchers from Nobel laureate David Baker's lab, secured $12.7 million and partnerships with Pfizer and Kite Pharma to develop AI-designed multi-target proteins aiming to improve disease treatment efficacy and reduce clinical trial costs.
Ascend analysis: Bay Area tops startup ROI with 10.07 MOIC; Boston 7.89 and Seattle 7.48 on $100M+ exits (2000–June 2025)
An Ascend analysis of U.S. startup ecosystems finds the Bay Area leads in capital efficiency with a MOIC of 10.07, followed by Boston (7.89) and surprise third-place Seattle (7.48), based on exits over $100M from 2000–mid‑2025; smaller metros generally underperform and selection/bias limitations are noted.
GeekWire Week in Review (May 14, 2023): Top stories include ex-CFO indicted over $35M crypto transfer, Bezos’ $500M yacht, and Amazon legal/personnel news
GeekWire's Week in Review for May 14, 2023 lists the site's most-read stories, including a Seattle startup ex-CFO indicted over an alleged $35M crypto transfer, Jeff Bezos' $500M yacht, and Amazon-related legal and personnel news.
See all 12 stories, episodes and videos about SeaGen.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Clay Siegall Former founder